BLOOD CLOTTING- benzethonium chloride and lidocaine aerosol, spray

Blood Clotting by

Drug Labeling and Warnings

Blood Clotting by is a Otc medication manufactured, distributed, or labeled by HART Health. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients

Benzethonium Chloride 0.2% w/w
Lidocaine 4% w/w

Purpose

Topical Antiseptic
Topical Anesthetic 

Uses

• for help in control of superficial bleeding
• for the temporary relief of paid
• to help protect against skin infection in minor cuts, scrapes, and burns

Warnings

For external use only

Flammable

• keep away from flame
• contents under pressure
• do not puncture or incinerate container
• do not expose to temperatures above 120°F

Do not use

• in or near the eyes or other mucus membranes
• over large portions of the body
• on deep or puncture wounds, raw surfaces, blistered areas, animal bites, or serious burns

Stop use and ask doctor if

• redness, swelling, or irritation occurs
• infection occurs
• condition persists or worsens
• symptoms persist for more than 7 days

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away. 1-800-222-1222

Directions

Adults and children 23 years of age and over:

• shake can well before using
• hold 6-8 inches from moist injured area
• spray until area is covered and superficial bleeding is stopped
• repeat as necessary
• scab-like cover will gradually disappear as healing takes place or may be removed with soap and water

Children under 12 years of age: ask a doctor

Other Information

• avoid inhaling
• use only as directed
• intentional misuse by deliberately concentrating and inhaling the contents may be harmful or fatal

Inactive Ingredients

isobutane, isopropyl myristate, karaya, n-butane, propane, silica, sorbitan monooleate, talc, tragacanth

Principal Display

INGREDIENTS AND APPEARANCE

BLOOD CLOTTING 
benzethonium chloride and lidocaine aerosol, spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 50332-0217
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	3400 mg  in 85 g
BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP)	BENZETHONIUM CHLORIDE	170 mg  in 85 g

Inactive Ingredients
Ingredient Name	Strength
ISOBUTANE (UNII: BXR49TP611)
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
KARAYA GUM (UNII: 73W9IQY50Q)
BUTANE (UNII: 6LV4FOR43R)
PROPANE (UNII: T75W9911L6)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
3-(TRIETHOXYSILYL)PROPYLAMINE (UNII: L8S6UBW552)
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)
TALC (UNII: 7SEV7J4R1U)
TRAGACANTH (UNII: 2944357O2O)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 50332-0217-1	85 g in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product	04/01/1974

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M	04/01/1974

Labeler - HART Health (069560969)